Avalon Investment & Advisory Abbott Laboratories Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Abbott Laboratories stock. As of the latest transaction made, Avalon Investment & Advisory holds 25,542 shares of ABT stock, worth $2.93 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

25,542

Previous 23,931 6.73%

Holding current value

$2.93 Million

Previous $2.63 Million 1.56%

% of portfolio

0.07%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $156,041 - $183,670	1,611 Added 6.73%	25,542 $2.59 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $37,453 - $43,938	394 Added 1.67%	23,931 $2.63 Million
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $1.48 Million - $1.71 Million	-15,251 Reduced 39.32%	23,537 $2.28 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $22.1 Million - $26.7 Million	-216,817 Reduced 84.83%	38,788 $4.21 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $1.3 Million - $1.59 Million	11,441 Added 4.69%	255,605 $30.3 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $3.31 Million - $4.05 Million	-28,633 Reduced 10.5%	244,164 $34.4 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $589,832 - $652,527	-5,056 Reduced 1.82%	272,797 $32.2 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $593,376 - $698,488	-5,609 Reduced 1.98%	277,853 $32.2 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $23.6 Million - $27.8 Million	-216,433 Reduced 43.3%	283,462 $34 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $755,055 - $822,794	7,191 Added 1.46%	499,895 $54.7 Million
Q3 2020 Nov 04, 2020	SELL	$91.64 - $111.29 $326,513 - $396,526	-3,563 Reduced 0.72%	492,704 $53.6 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $2.16 Million - $2.76 Million	-28,182 Reduced 5.37%	496,267 $45.4 Million
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $1.49 Million - $2.18 Million	23,690 Added 4.73%	524,449 $41.4 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $736,345 - $819,724	-9,379 Reduced 1.84%	500,759 $43.5 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1.41 Million - $1.53 Million	-17,219 Reduced 3.27%	510,138 $42.7 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $21.5 Million - $25 Million	294,584 Added 126.55%	527,357 $44.4 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $82,775 - $100,075	-1,250 Reduced 0.53%	232,773 $18.6 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $15 Million - $16.9 Million	228,123 Added 3866.49%	234,023 $16.9 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $15,020 - $18,119	-247 Reduced 4.02%	5,900 $433,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $14,392 - $15,885	-250 Reduced 3.91%	6,147 $375,000
Q1 2018 Jun 26, 2018	BUY	$56.27 - $63.62 $116,591 - $131,820	2,072 Added 47.91%	6,397 $383,000
Q1 2018 Jun 22, 2018	SELL	$56.27 - $63.62 $116,591 - $131,820	-2,072 Reduced 32.39%	4,325 $247,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $116,591 - $131,820	2,072 Added 47.91%	6,397 $383,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $19,646 - $21,034	-366 Reduced 7.8%	4,325 $247,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $13 Million - $14.5 Million	-269,845 Reduced 98.29%	4,691 $250,000
Q2 2017 Aug 14, 2017	BUY	N/A	274,536	274,536 $13.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Abbott Laboratories Transaction History